Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensus-Reference-Cited by-同舟云学术

Criteria for choosing clinically effective glaucoma treatment: A discussion panel consensus

Published:2007-05 Issue:3 Volume:68 Page:127-136
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Thygesen John,Burk Reinhard,Carassa Roberto,Crichton Andrew,Goñi Francisco Javier,Menage Mitch,Miglior Stefano,Montgomery Donald,Nordmann John-Philippe,Roberts Tim,Singh Kuldev

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference18 articles.

1. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss;Sommer;Arch Ophthalmol,1991

2. Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial;Leske;Arch Ophthalmol,2003

3. Incidence of open-angle glaucoma: The Barbados Eye Studies;Leske;Arch Ophthalmol,2001

4. Risk factors for open-angle glaucoma. The Barbados Eye Study;Leske;Arch Ophthalmol,1995

5. The Ocular Hypertension Treatment Study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma;Kass;Arch Ophthalmol,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles for the treatment of glaucoma-associated neuroinflammation;Eye and Vision;2022-07-02

2. Over-diagnosis and over-treatment in Ophthalmology: A review of the literature;Archivos de la Sociedad Española de Oftalmología (English Edition);2016-11

3. Sobrediagnóstico y sobretratamiento en Oftalmología: revisión de la literatura;Archivos de la Sociedad Española de Oftalmología;2016-11

4. Direct cost and predictive factors for treatment in patients with ocular hypertension or early, moderate and advanced primary open-angle glaucoma: the CoGIS study in Germany;Graefe's Archive for Clinical and Experimental Ophthalmology;2013-04-30

5. Improvement of Acetazolamide Ocular Permeation Using Ascorbyl Laurate Nanostructures as Drug Delivery System;Journal of Ocular Pharmacology and Therapeutics;2012-04